Phase II study of use of a single cycle of induction chemotherapy and concurrent chemoradiotherapy containing capecitabine/cisplatin followed by surgery for patients with resectable esophageal squamous cell carcinoma: Long-term follow-up data

Cancer Chemotherapy and Pharmacology

Volumn 69, Issue 3, 2012, Pages 655-663

  Koo, Dong Hoe ^a   Park, Seung Il ^a   Kim, Yong Hee ^a   Kim, Jong Hoon ^a   Jung, Hwoon Yong ^a   Lee, Gin Hyug ^a   Choi, Kee Don ^a   Song, Ho June ^a   Song, Ho Young ^a   Shin, Ji Hoon ^a   Cho, Kyung Ja ^a   Yoon, Dok Hyun ^a   Kim, Sung Bae ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Combined modality therapy; Esophageal neoplasm; Phase II clinical trial; Squamous cell carcinoma; Survival

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CAPECITABINE; CISPLATIN;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER LOCALIZATION; CANCER PATIENT; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CHEMORADIOTHERAPY; CHEMOTHERAPY INDUCED EMESIS; DISTANT METASTASIS; DRUG EFFICACY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGITIS; ESOPHAGUS RESECTION; ESOPHAGUS SURGERY; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HAND FOOT SYNDROME; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NAUSEA; NEPHROTOXICITY; NEUTROPENIA; OVERALL SURVIVAL; PHASE 2 CLINICAL TRIAL; PNEUMONIA; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIATION DOSE FRACTIONATION; SIDE EFFECT; SURVIVAL RATE; SURVIVAL TIME; THROMBOCYTOPENIA; TREATMENT RESPONSE;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; CISPLATIN; DEOXYCYTIDINE; DISEASE-FREE SURVIVAL; DRUG ADMINISTRATION SCHEDULE; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEASIBILITY STUDIES; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; INDUCTION CHEMOTHERAPY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; TIME FACTORS;

EID: 84859786261     PISSN: 03445704     EISSN: 14320843     Source Type: Journal    
DOI: 10.1007/s00280-011-1750-5     Document Type: Article

References (27)

1. Urschel JD, Vasan H (2003) A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer. Am J Surg 185(6):538-543. doi:10.1016/s0002- 9610(03)00066-7 (Pubitemid 36627845)
2. Wobst A, Audisio RA, Colleoni M, Geraghty JG (1998) Oesophageal cancer treatment: studies, strategies and facts. Ann Oncol 9(9):951-962 (Pubitemid 28496702)
3. Ajani JA, Barthel JS, Bekaii-Saab T, Bentrem DJ, D'Amico TA, Fuchs CS, Gerdes H, Hayman JA, Hazard L, Ilson DH, Kleinberg LR, McAleer MF, Meropol NJ, Mulcahy MF, Orringer MB, Osarogiagbon RU, Posey JA, Sasson AR, Scott WJ, Shibata S, Strong VE, Swisher SG, Washington MK, Willett C, Wood DE, Wright CD, Yang G (2008) Esophageal cancer. J Natl Compr Canc Netw 6(9):818-849
4. Suntharalingam M, Moughan J, Coia LR, Krasna MJ, Kachnic L, Haller DG, Willet CG, John MJ, Minsky BD, Owen JB (2005) Outcome results of the 1996-1999 patterns of care survey of the national practice for patients receiving radiation therapy for carcinoma of the esophagus. J Clin Oncol 23(10):2325-2331. doi: 10.1200/jco.2005.00.448 (Pubitemid 46218725)
5. Bosset J-F, Gignoux M, Triboulet J-P, Tiret E, Mantion G, Elias D, Lozach P, Ollier J-C, Pavy J-J, Mercier M, Sahmoud T, Ségol P, Flamant J-B, Arnaud J-P, Plachot J-P, Mandard A-M, Chaillard G (1997) Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med 337(3):161-167. doi:10.1056/NEJM199707173370304 (Pubitemid 27306287)
6. Urba SG, Orringer MB, Turrisi A, Iannettoni M, Forastiere A, Strawderman M (2001) Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 19(2):305-313 (Pubitemid 32112841)
7. Burmeister BH, Smithers BM, Gebski V, Fitzgerald L, Simes RJ, Devitt P, Ackland S, Gotley DC, Joseph D, Millar J, North J, Walpole ET, Denham JW (2005) Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial. Lancet Oncol 6(9):659-668. doi:10.1016/s1470-2045(05)70288-6 (Pubitemid 41222756)
8. Tepper J, Krasna MJ, Niedzwiecki D, Hollis D, Reed CE, Goldberg R, Kiel K, Willett C, Sugarbaker D, Mayer R (2008) Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. J Clin Oncol 26(7):1086-1092. doi:10.1200/jco.2007.12.9593
9. Stahl M, Walz MK, Stuschke M, Lehmann N, Meyer HJ, Riera-Knorrenschild J, Langer P, Engenhart-Cabillic R, Bitzer M, Konigsrainer A, Budach W, Wilke H (2009) Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction. J Clin Oncol 27(6):851-856 Epub 2009 Jan 12
10. Val G, Bryan B, Smithers BM, Kerwyn F, John Z, John S (2007) Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol 8(3):226-234 (Pubitemid 46291702)
11. Kim SB, Kim SH, Lee KH, Lee JW, Kim SW, Suh CW, Lee JS, Song HY, Chang HS, Choi EK, Park SI, Choe GY, Kim HR, Min YI, Sohn KH (1995) Preoperative chemoradiotherapy for locoregional esophageal cancer: preliminary report. J Korean Med Sci 10(2):111-120
12. Lee J-L, Kim S-B, Jung H-Y, Park S-I, Kim D-K, Kim J-H, Song H-Y, Kim W-K, Lee J-S, Min Y-I (2003) Efficacy of neoadjuvant chemoradiotherapy in resectable esophageal squamous cell carcinoma. Acta Oncol 42(3):207-217. doi:10.1080/02841860310010736 (Pubitemid 36745635)
13. Lee J-L, Park SI, Kim S-B, Jung H-Y, Lee GH, Kim J-H, Song H-Y, Cho K-J, Kim W-K, Lee J-S, Kim S-H, Min Y-I (2004) A single institutional phase III trial of preoperative chemotherapy with hyperfractionation radiotherapy plus surgery versus surgery alone for resectable esophageal squamous cell carcinoma. Ann Oncol 15(6):947-954. doi:10.1093/annonc/mdh219 (Pubitemid 39004352)
14. Ishikawa T, Utoh M, Sawada N, Nishida M, Fukase Y, Sekiguchi F, Ishitsuka H (1998) Tumor selective delivery of 5-fluorouracil by capecitabine, a new oral fluoropyrimidine carbamate, in human cancer xenografts. Biochem Pharmacol 55(7):1091-1097. doi: 10.1016/s0006-2952(97)00682-5 (Pubitemid 28167730)
15. Vaishampayan UN, Ben-Josef E, Philip PA, Vaitkevicius VK, Du W, Levin KJ, Shields AF (2002) A single-institution experience with concurrent capecitabine and radiation therapy in gastrointestinal malignancies. Int J Radiat Oncol Bioly Phys 53(3):675-679. doi:10.1016/s0360-3016(02)02772-4 (Pubitemid 34626506)
16. Lee J, Im Y-H, Kang JH, Nam E, Lee S-H, Park J-O, Park Y-S, Kang WK, Park K (2005) Phase II study of capecitabine and cisplatin as first-line therapy in patients with recurrent or metastatic esophageal carcinoma. J Clin Oncol (Meeting Abstracts) 23(16 suppl):4221
17. Lee SS, Kim S-B, Park S-I, Kim YH, Ryu J-S, Song H-Y, Shin JH, Jung HY, Lee GH, Choi KD, Cho K-J, Kim JH (2007) Capecitabine and cisplatin chemotherapy (XP) alone or sequentially combined chemoradiotherapy containing XP regimen in patients with three different settings of stage IV esophageal cancer. Jpn J Clin Oncol 37(11):829-835. doi:10.1093/jjco/hym117 (Pubitemid 350259001)
18. Jin J, Liao Z, Zhang Z, Ajani J, Swisher S, Chang JY, Jeter M, Guerrero T, Stevens CW, Vaporciyan A, Putnam J, Walsh G, Smythe R, Roth J, Yao J, Allen P, Cox JD, Komaki R (2004) Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery. Int J Radiat Oncol Biol Phys 60(2):427-436. doi:10.1016/j.ijrobp.2004. 03.033 (Pubitemid 39233461)
19. Malaisrie SC, Hofstetter WL, Correa AM, Ajani JA, Komaki RR, Rice DC, Vaporciyan AA, Walsh GL, Roth JA,WuTT, Swisher SG (2006) The addition of induction chemotherapy to preoperative, concurrent chemoradiotherapy improves tumor response in patients with esophageal adenocarcinoma. Cancer 107(5):967-974. doi:10.1002/cncr.22077 (Pubitemid 44291145)
20. Courrech Staal EFW, Aleman BMP, Boot H, van Velthuysen MLF, van Tinteren H, van Sandick JW (2010) Systematic review of the benefits and risks of neoadjuvant chemoradiation for oesophageal cancer. Br J Surg 97(10):1482-1496. doi:10.1002/bjs.7175
21. Kim DW, Blanke CD, Wu H, Shyr Y, Berlin J, Beauchamp RD, Chakravarthy B (2007) Phase II study of preoperative paclitaxel/cisplatin with radiotherapy in locally advanced esophageal cancer. Int J Radiat Oncol Biol Phys 67(2):397-404. doi: 10.1016/j.ijrobp.2006.08.062 (Pubitemid 46108316)
22. Stahl M, Vanhoefer U, Stuschke M, Walz MK, Müller C, Wilke H (1998) Pre-operative sequential chemo- and radiochemotherapy in locally advanced carcinomas of the lower oesophagus and gastro-oesophageal junction. Eur J Cancer 34(5):668-673. doi: 10.1016/s0959-8049(97)10109-5 (Pubitemid 28218942)
23. Kim MK, Cho K-J, Park S-I, Kim YH, Kim JH, Song H-Y, Shin JH, Jung HY, Lee GH, Choi KD, Song HJ, Ryu J-S, Kim S-B (2009) Initial Stage affects survival even after complete pathologic remission is achieved in locally advanced esophageal cancer: analysis of 70 patients with pathologic major response after preoperative chemoradiotherapy. Int J Radiat Oncol Biol Phys 75(1):115-121. doi:10.1016/j.ijrobp.2008.10.074
24. Donahue JM, Nichols FC, Li Z, Schomas DA, Allen MS, Cassivi SD, Jatoi A, Miller RC, Wigle DA, Shen KR, Deschamps C (2009) Complete pathologic response after neoadjuvant chemoradiotherapy for esophageal cancer is associated with enhanced survival.Ann Thorac Surg 87(2):392-399. doi:10.1016/j.athoracsur.2008. 11.001
25. Rizk NP, Seshan VE, Bains MS, Ilson DH, Minsky BD, Tang L, Rusch VW (2007) Prognostic factors after combined modality treatment of squamous cell carcinoma of the esophagus. J Thorac Oncol 2(12):1117-1123. doi:1110.1097/JTO. 1110b1013e31815bfe31853
26. Tamim WZ, Davidson RS, Quinlan RM, O'Shea MA, Orr RK, Swanson RS (1998) Neoadjuvant chemoradiotherapy for esophageal cancer: is it worthwhile? Arch Surg 133(7):722-726. doi: 10.1001/archsurg.133.7.722 (Pubitemid 28324151)
27. Urba S, Wolf G, Eisbruch A, Worden F, Lee J, Bradford C, Teknos T, Chepeha D, Prince M, Hogikyan N, Taylor J (2006) Single-cycle induction chemotherapy selects patients with advanced laryngeal cancer for combined chemoradiation: a new treatment paradigm. J Clin Oncol 24(4):593-598. doi:10.1200/jco.2005.01.2047 (Pubitemid 46630421)